ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CEL Celadon Pharmaceuticals Plc

61.00
1.50 (2.52%)
22 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Celadon Pharmaceuticals Plc LSE:CEL London Ordinary Share GB00BDQYGP38 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.50 2.52% 61.00 57.00 65.00 61.00 59.50 59.50 12,246 14:00:11
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Investment Advice 149k -7.14M -0.1082 -5.64 39.26M

Holding(s) in Company

17/10/2008 4:13pm

UK Regulatory


    RNS Number : 1435G
  Celsis International PLC
  17 October 2008
   


 For filings with the FSA include the annex
 For filings with issuer exclude the annex 

 TR-1: Notifications of Major Interests in Shares

 1. Identity of the issuer or the underlying issuer   CELSIS INTERNATIONAL
 of existing shares to which voting rights are                         PLC
 attached:


 2. Reason for notification (yes/no)
                                                                             YES
 An acquisition or disposal of voting rights

 An acquisition or disposal of financial instruments which may result in
 the acquisition of shares already issued to which voting rights are
 attached 

 An event changing the breakdown of voting rights

 Other (please specify):______________

 3. Full name of person(s)       NORTH ATLANTIC VALUE
 subject to notification            LLP(AS INVESTMENT
 obligation:                         MANAGER/ADVISOR)
                                              1. ORYX
 4. Full name of shareholder(s)  INTERNATIONAL GROWTH
 (if different from 3):                  FUND LIMITED


                                    2. NORTH ATLANTIC
                                        VALUE LLP (AS
                                  INVESTMENT MANAGER)
                                      10 OCTOBER 2008
 5. Date of transaction (and
 date on which the threshold is
 crossed or reached if
 different):
                                      13 OCTOBER 2008
 6. Date on which issuer
 notified:
                                        TOTAL HOLDING
 7. Threshold(s) that is/are     INCREASED THROUGH 7%
 crossed or reached:


 8: Notified Details
 A: Voting rights attached to shares

 Class/type of shares            Situation previous to the triggering        Resulting situation after the triggering transaction
 If possible use ISIN code       transaction
                                 Number of shares      Number of voting      Number of shares     Number of voting rights          
Percentage of voting
                                                       rights                                                                       rights

                                                                                                  Direct                Indirect    Direct  
        Indirect
 ORDINARY SHARES SEDOL:
 B0CD5F6                                                                                                                                    
      
                                                                                                                                            
      
 HOLDER 1                                                                                                                                   
      
                                                                                                                                            
      
 HOLDER 2                                   1,500,000             1,500,000            1,500,000             1,500,000                      
 6.85%
                                                                                                                                            
      
                                                    0                     0               50,000                50,000                      
 0.23%
                                                                                                                                            
      
                                                                                                                 TOTAL                      
 7.07%



 B: Financial Instruments

 Resulting situation after the triggering transaction

 Type of financial instrument  Expiration date  Exercise/ conversion  No. of voting rights  Percentage of voting
                                                period/date           that may be acquired  rights
                                                                      (if the instrument
                                                                      exercised/converted)




 Total (A+B)

 Number of voting rights  Percentage of voting rights
 1,550,000                                      7.07%



 9. Chain of controlled undertakings through which the voting rights and /or
 the financial instruments are effectively held, if applicable:
 NOT APPLICABLE

 Proxy Voting:

 10. Name of proxy holder:                                         N/A

 11. Number of voting rights proxy holder will cease to hold:      N/A

 12. Date on which proxy holder will cease to hold voting rights:  N/A


 13. Additional information:        NORTH ATLANTIC VALUE LLP IS THE INVESTMENT
                                  MANAGER/ADVISOR IN RESPECT OF THE FULL 7.07%
                                 HOLDING AS IT IS INVESTMENT MANAGER TO HOLDER
                                     1 AS WELL AS THE OTHER CLIENT INCLUDED IN
                                                                     HOLDER 2.
 14 Contact name:                                               BONITA GUNTRIP

 15. Contact telephone number:                                   020 7747 5681


    For notes on how to complete form TR-1 please see the FSA website. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
HOLUBOSRWKRRAAA

1 Year Celadon Pharmaceuticals Chart

1 Year Celadon Pharmaceuticals Chart

1 Month Celadon Pharmaceuticals Chart

1 Month Celadon Pharmaceuticals Chart